To control and mitigate the potential presence of mutagenic impurities like nitrosamines in medicines, pharmaceutical companies face strict regulatory guidelines. Scientists need to have robust and precise analytical methodologies to accurately detect and quantify the presence of nitrosamines and their precursors. Waters delivers accessible LC-MS and MS/MS solutions to resolve these challenges and help you confidently take mitigating action against nitrosamines and make critical decisions.
From the inception of drug development to the rigors of manufacturing quality control (QC), partnering with Waters means you can leverage powerful technologies to navigate regulatory guidelines, ensure patient safety, and support an ongoing supply of critical medicines.
eBook: Nitrosamines Analysis with LC-MS/MS
Pharmaceutical manufacturers strive to control or mitigate the presence of potentially harmful nitrosamines in their drug products. Discover how Waters can support you as your analytical sidekick providing comprehensive end-to-end workflows for sensitive and robust quantitative measurements of nitrosamines.
Download this eBook to learn how you can support drug safety and quality testing through comprehensive nitrosamine analysis solutions.
Pharmaceutical manufacturers strive to control or mitigate the presence of potentially harmful nitrosamines in their drug products. Discover how Waters can support you as your analytical sidekick providing comprehensive end-to-end workflows for sensitive and robust quantitative measurements of nitrosamines.
Download this eBook to learn how you can support drug safety and quality testing through comprehensive nitrosamine analysis solutions.